LINDSAY A MD ROSENWALD
CIK 941841 · PRESIDENT, CEO & CHAIRMAN · last filed 2026-03-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$108.68M
Companies
9
Total Filings
101
Lifetime Open-Market Net
$12.02M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FBIOP | PRESIDENT, CEO & CHAIRMAN | 4,586,841 | $20.71 | $94.99M | $7.68M | 24 | 2026-03-20 |
| DERM | Director | 387,616 | $6.34 | $2.46M | $321.4K | 7 | 2025-08-07 |
| Checkpoint Therapeutics, Inc. (CKPT) Delisted | Director | 157,007 | $4.26 | $668.8K | $356.2K | 12 | 2025-05-30 |
| ATXI | Director | 354,318 | $0.35 | $124.9K | $543.7K | 7 | 2024-09-25 |
| MBIO | Director | 60,525 | $0.74 | $44.8K | $758.1K | 12 | 2023-07-07 |
| FBIO | PRESIDENT, CEO | 120,000 | $2.77 | $332.4K | $1.01M | 6 | 2017-11-08 |
| Origo Acquisition Corp (CNLM.W) Delisted | Co-Chairman and CEO | 265,000 | — | — | $0 | 2 | 2016-05-23 |
| Fortress Biotech, Inc. (CNDO) Delisted | President and CEO | 4,962,304 | — | — | $1.36M | 16 | 2014-12-03 |
| NVD | 10%+ Owner | 2,137,660 | $5.02 | $10.73M | $0 | 1 | 2007-01-23 |
Recent Filings · Page 9 of 11
101 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-01-20 | Fortress Biotech, Inc. (CNDO) Delisted | Buy (P) | +2,000 | $11.3K | EDGAR |
| 2012-01-19 | Fortress Biotech, Inc. (CNDO) Delisted | Buy (P) | +2,000 | $11.3K | EDGAR |
| 2012-01-18 | Fortress Biotech, Inc. (CNDO) Delisted | Buy (P) | +2,000 | $11.3K | EDGAR |
| 2012-01-17 | Fortress Biotech, Inc. (CNDO) Delisted | Buy (P) | +2,000 | $10.8K | EDGAR |
| 2012-01-13 | Fortress Biotech, Inc. (CNDO) Delisted | Buy (P) | +2,000 | $10.8K | EDGAR |
| 2012-01-12 | Fortress Biotech, Inc. (CNDO) Delisted | Buy (P) | +4,000 | $21.4K | EDGAR |
| 2011-12-09 | — | Buy (P) | +2,000 | $14.0K | |
| 2011-11-17 | — | Other (J) | — | $0 | |
| 2007-08-01 | — | Exer (X) | +10,000 | $45.0K | |
| 2007-06-13 | — | Grant (A) | — | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.